Clinical trials
Trials in Iraq with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
310 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 9 |
| 2019 | 7 |
| 2020 | 10 |
| 2021 | 21 |
| 2022 | 41 |
| 2023 | 33 |
| 2024 | 48 |
| 2025 | 57 |
| 2026 | 62 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 169 |
| Unknown status | 45 |
| Not yet recruiting | 32 |
| Recruiting | 32 |
| Active, not recruiting | 25 |
| Enrolling by invitation | 4 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Baghdad | 105 |
| Hawler Medical University | 34 |
| Al-Mustansiriyah University | 16 |
| University of Sulaimani | 11 |
| Kufa University | 9 |
| Karbala University | 6 |
| University of Mosul | 6 |
| Al-Rasheed University College | 5 |
| Omer Othman Abdullah | 5 |
| University of Duhok | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Periodontitis | 12 |
| Pain | 10 |
| Anxiety Disorders | 8 |
| Diabetes Mellitus, Type 2 | 7 |
| Agnosia | 5 |
| Kidney Failure, Chronic | 5 |
| Periodontal Diseases | 5 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 1 | 4 |
| Fatigue | 4 |
Trials
Showing 1 to 25 of 310. Each trial links to its page on Pharma Observatory.
210 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.